Phase 1 Trial of Faecalibacterium prausnitzii Supports Microbiome Based Therapy in Crohn’s Disease

Home News Phase 1 Trial of Faecalibacterium prausnitzii Supports Microbiome Based Therapy in Crohn’s Disease